Retatrutide – Research Peptide
Retatrutide is a novel multi-receptor research compound studied for its activity across three key metabolic pathways: the GLP-1 receptor, GIP receptor, and glucagon receptor. This triple-receptor profile has made Retatrutide a significant area of interest in metabolic, weight-management, glucose-regulation, and liver-health research.
In research settings, GLP-1 receptor activation is associated with insulinotropic signalling, appetite regulation, delayed gastric emptying, and improved satiety pathways. GIP receptor activity is being investigated for its potential role in insulin sensitivity, lipid metabolism, and its synergistic interaction with GLP-1 pathways. Glucagon receptor activation is also being studied for its involvement in energy expenditure and hepatic fat metabolism.
Retatrutide is currently being explored in scientific studies relating to obesity, type 2 diabetes, metabolic dysfunction, and non-alcoholic fatty liver disease research.
At R&R Peptides, our Retatrutide is supplied for laboratory and research purposes only. It is not intended for human consumption, medical use, diagnosis, treatment, or prevention of any disease.
